5. Pharmacokinetics of 2,3,7,8-Tetrachlorodibenzo-P-Dioxin and Related Compounds

  1. Arnold Schecter
  1. James R. Olson

Published Online: 30 MAR 2012

DOI: 10.1002/9781118184141.ch5

Dioxins and Health: Including Other Persistent Organic Pollutants and Endocrine Disruptors, Third Edition

Dioxins and Health: Including Other Persistent Organic Pollutants and Endocrine Disruptors, Third Edition

How to Cite

Olson, J. R. (2012) Pharmacokinetics of 2,3,7,8-Tetrachlorodibenzo-P-Dioxin and Related Compounds, in Dioxins and Health: Including Other Persistent Organic Pollutants and Endocrine Disruptors, Third Edition (ed A. Schecter), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9781118184141.ch5

Editor Information

  1. Department of Environmental and Occupational Health Sciences, University of Texas School of Public Health, Dallas, TX, USA

Author Information

  1. University at Buffalo, State University of New York (SUNY), Buffalo, New York, USA

Publication History

  1. Published Online: 30 MAR 2012
  2. Published Print: 6 APR 2012

ISBN Information

Print ISBN: 9780470605295

Online ISBN: 9781118184141

SEARCH

Keywords:

  • pharmacokinetics of 2,3,7,8-TCDD, and related compounds;
  • PCDD, PCDF, PCB Net excretion, congener dependent;
  • PB-PK models for 2,3,7,8-TCDD, disposition of chemical

Summary

This chapter contains sections titled:

  • Introduction

  • Absorption/Bioavailability Following Exposure

  • Distribution

  • Metabolism and Excretion

  • Physiologically Based Pharmacokinetic Models

  • Pharmacokinetics in Special Populations

  • References